Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Clinical trial NCT05969938 · UNKNOWN

Trial details

NCT number: NCT05969938
Sponsor: WeiWei Xiao
Status: UNKNOWN
Study type: OBSERVATIONAL

Rectal Adenocarcinoma Circulating Tumor DNA Minimal Residual Disease Neoadjuvant Chemoradiotherapy

Start date: 2023-06-21
Primary completion: 2024-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.